Treatment of endocarditis with teicoplanin: A retrospective analysis of 104 cases

Journal of Antimicrobial Chemotherapy

Volumn 38, Issue 3, 1996, Pages 507-521

  Wilson, A P R ^a   Gaya, H ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; GENTAMICIN; RIFAMPICIN; TEICOPLANIN; THEOPHYLLINE; VANCOMYCIN;

ARTICLE; BACTERIAL ENDOCARDITIS; BRAIN HEMORRHAGE; CHEMOTHERAPY; CHOLESTASIS; CLINICAL TRIAL; DIARRHEA; EMBOLISM; ENDOCARDITIS; FEMALE; FEVER; FLUSHING; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEMOLYSIS; HOSPITAL; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NAUSEA; RASH; RETROSPECTIVE STUDY; SICK SINUS SYNDROME; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS; STREPTOCOCCUS SANGUINIS; THROMBOCYTOPENIA; VERTIGO;

ADULT; AGED; ANTI-BACTERIAL AGENTS; AORTIC VALVE; ENDOCARDITIS; FEMALE; FEVER; FUSIDIC ACID; GENTAMICINS; HUMANS; LONDON; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROSTHESES AND IMPLANTS; RETROSPECTIVE STUDIES; RIFAMPIN; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS SANGUIS; TEICOPLANIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 0029828690     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/38.3.507     Document Type: Article

References (33)

1. Altman, D. G. & Gardner, M. J. (1989). Calculating confidence intervals for means and their differences. In Statistics with Confidence (Gardner, M. J., & Altman, D. G., Eds), pp. 20-7. British Medical Journal, London.
2. Armitage, P. & Berry, G. (1987). Statistical Methods in Medical Research, 2nd edn. Blackwell Scientific Publications, Oxford.
3. Brogden, R. N. & Peters, D. H. (1994). Teicoplanin. A reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 47, 823-54.
4. Carver, P. L., Nightingale, C. H., Quintiliani, R., Sweeney, K., Stevens, R. C. & Maderazo, E. (1989). Pharmacokinetics of single- and multiple-dose teicoplanin in healthy volunteers. Antimicrobial Agents and Chemotherapy 33, 82-6.
5. Cavenaghi, L., Corti, A. & Cassani, G. (1986). Comparison of the solid phase enzyme receptor assay (SPERA) and the microbiological assay for teicoplanin. Journal of Hospital Infection 7, Suppl. A, 85-89.
6. Chambers, H. F. & Kennedy, S. (1990). Effects of dosage, peak and trough concentrations in serum, protein binding, and bactericidal rate on efficacy of teicoplanin in a rabbit model of endocarditis. Antimicrobial Agents and Chemotherapy 34, 510-4.
7. Cremieux, A. C., Maziere, B., Vallois, J. M., Ottaviani, M., Azancot, A., Raffoul, H. et al. (1989). Evaluation of antibiotic diffusion into cardiac vegetations by quantitative autoradiography. Journal of Infectious Diseases 159, 938-44.
8. Davey, P. G. & Williams, A. H. (1991a). Teicoplanin monotherapy of serious infections caused by gram-positive bacteria: a re-evaluation of patients with endocarditis or Staphylococcus aureus bacteremia from a European open trial. Journal of Antimicrobial Chemotherapy 27, Suppl. B, 43-50.
9. Davey, P. G. & Williams, A. H. (1991b). A review of the safety profile of teicoplanin. Journal of Antimicrobial Chemotherapy 27, Suppl. B, 69-73.
10. Durack, D. T., Lukes, A. S., Bright, D. K. and the Duke Endocarditis Service. (1994). New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. American Journal of Medicine 96, 200-9.
11. Fernandez-Guerrero, M., Gobernado, M., Ariza, J. & Williams, A. (1990). Spanish experience with teicoplanin. Scandinavian Journal of Infectious Diseases, Suppl. 72, 38-44.
12. Gilbert, D. N., Wood, C. A., Kimbrough, R. C. and the Infectious Disease Consortium of Oregon. (1991). Failure of treatment with teicoplanin at 6 milligrams/kilogram/day in patients with Stephylococcus aureus intravascular infection. Antimicrobial Agents and Chemotherapy 35, 79-87.
13. Glupczynski, Y., Lagast, H., Van der Auwera, P., Thys, J. P., Crokaert, F., Yourassowsky, E. et al. (1986). Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria. Antimicrobial Agents and Chemotherapy 29, 52-7.
14. Harding, I. & Garaud, J. J. (1988). Teicoplanin in the treatment of infections caused by coagulase-negative staphylococci. Journal of Antimicrobial Chemotherapy 21, Suppl. A, 93-103.
15. Leport, C., Perronne, C., Massip, P., Canton, P., Leclercq, P., Bernard, E. et al. (1989). Evaluation of teicoplanin for treatment of endocarditis caused by gram-positive cocci in 20 patients. Antimicrobial Agents and Chemotherapy 33, 871-6.
16. Lewis, P., Garaud, J. J. & Parenti, F. (1988). A multicentre open clinical trial of teicoplanin in infections caused by gram-positive bacteria. Journal of Antimicrobial Chemotherapy 21, Suppl. A, 61-7.
17. Martino, P., Venditti, M., Micozzi, A., Brandimarte, C., Gentile, G., Santini, C. et al. (1989). Teicoplanin in the treatment of gram-positive bacterial endocarditis. Antimicrobial Agents and Chemotherapy 33, 1329-34.
18. Patton, K. R., Beg, A., Felmingham, D., Ridgway, G. L. & Grüneberg, R. N. (1987). Determination of teicoplanin concentration in serum using a bioassay technique. Drugs under Experimental and Clinical Research 13, 547-50.
19. Presterl, E., Graninger, W. & Georgopoulos, A. (1993). The efficacy of teicoplanin in the treatment of endocarditis caused by gram-positive bacteria. Journal of Antimicrobial Chemotherapy 31, 755-66.
20. Rowland, M. (1990). Clinical pharmacokinetics of teicoplanin. Clinical Pharmacokinetics 18, 184-209.
21. Rybak, M. J., Albrecht, L. M., Boike, S. C. & Chandrasekar, P. H. (1990). Nephrotoxicity of vancomycin, alone and with an aminoglycoside. Journal of Antimicrobial Chemotherapy 25, 679-87.
22. Rybak, M. J., Lerner, S. A., Levine, D. P., Albrecht, L. M., McNeil, P. L., Thompson, G. A. et al. (1991). Teicoplanin pharmacokinetics in intravenous drug abusers being treated for bacterial endocarditis. Antimicrobial Agents and Chemotherapy 35, 696-700.
23. Small, P. M. & Chambers, H. F. (1990). Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrobial Agents and Chemotherapy 34, 1227-31.
24. Sorrell, T. C. & Collignon, P. J. (1985). A prospective study of adverse reactions associated with vancomycin therapy. Journal of Antimicrobial Chemotherapy 16, 235-41.
25. Venditti, M., Gelfusa, V., Serra, P., Brandimarte, C., Micozzi, A. & Martino, P. (1992). 4-Week treatment of streptococcal native valve endocarditis with high-dose teicoplanin. Antimicrobial Agents and Chemotherapy 36, 723-6.
26. Watanakunakorn, C. (1994). Staphylococcus aureus endocarditis at a community teaching hospital, 1980 to 1991. Archives of Internal Medicine 154, 2330-6.
27. Wells, A. U., Fowler, C. C., Ellis-Pegler, R. B., Luke, R., Hannan, S. & Sharpe, D. N. (1990). Endocarditis in the 80s in a general hospital in Auckland, New Zealand. Quarterly Journal of Medicine 76, 763-62.
28. White, L. O., McMullin, C., Davis, A. J., MacGowan, A. P., Harding, I. Reeves, D. S. (1996). The quality of clinical serum teicoplanin assays: an experimental European EQA distribution. Journal of Antimicrobial Chemotherapy 38, in press.
29. Wilson, A. P. R. & Grüneberg, R. N. (1994). Use of teicoplanin in community medicine. European Journal of Clinical Microbiology and Infectious Disease 13, 710-10.
30. Wilson, A. P. R., Grüneberg, R. N. & Neu, H. (1994). A critical review of the dosage of teicoplanin in Europe and the USA. International Journal of Antimicrobial Agents 4, Suppl. 1, S1-30.
31. Wilson, W. R., Gilbert, D. N., Bisno, A. L. et al. (1993). General guidelines for the evaluation of new anti-infective drugs for the treatment of infective endocarditis. Modified European Guidelines. In European Guidelines for the Clinical Evaluation of Anti-infective Drug Products (Beam, T. R., Gilbert, D. N., Kunin, C. M. & European Working Party, Eds), pp. 112-9. European Society of Clinical Microbiology and Infectious Diseases.
32. Working Party of the British Society for Antimicrobial Chemotherapy (1985). Antibiotic treatment of streptococcal and staphylococcal endocarditis. Lancet ii, 815-7.
33. Yu, V. L., Fang, G. D., Keys, T. F., Harris, A. A., Gentry, L. O., Fuchs, P. C. et al. (1994). Prosthetic valve endocarditis: superiority of surgical valve replacement versus medical therapy only. Annals of Thoracic Surgery 58, 1073-7.